Robert J. Michel's Insider Trades & SAST Disclosures
Robert J. Michel's most recent trade in Bio-Key International Inc. was a trade of 3,897 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert J. Michel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 3,897 | 17,303 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 2,971 | 13,406 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 10 Mar 2025 | 1,000 | 17,050 (0%) | 0% | 8 | 8,000 | Daxor Common Stock |
| Geron Corp. | Michelle Robertson J. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 656,000 | 656,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Michelle Robertson J. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 110,000 | 110,000 | - | - | Restricted Stock Units | |
| Daxor Corp. | Robert J. Michel | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Dec 2024 | 4,750 | 15,050 (0%) | 0% | 0 | Daxor Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 2,587 | 10,435 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 3,500 | 7,172 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 676 | 7,848 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 1,429 | 3,672 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.70 per share. | 27 Mar 2024 | 750 | 11,300 (0%) | 0% | 8.7 | 6,525 | Daxor Common Stock |
| Daxor Corp. | Robert Michel J. | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.75 per share. | 06 Dec 2023 | 120 | 10,550 (0%) | 0% | 7.8 | 930 | Daxor Common Stock |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 1,819 | 35,365 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 4,412 | 33,546 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 14,000 | 14,000 | - | - | Stock Options (right to buy) | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 4,348 | 29,134 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,429 | 24,786 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 3,847 | 23,357 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 2,098 | 18,810 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 700 | 19,510 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 544 | 16,712 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 1,383 | 16,168 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 474 | 14,785 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,539 | 14,311 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 414 | 12,772 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,000 | 12,358 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,738 | 7,358 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 162 | 5,620 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 323 | 5,458 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 164 | 5,135 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 312 | 4,971 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 2,000 | 6,250 (0%) | 0% | 0 | Daxor Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 152 | 4,659 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 323 | 4,507 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 10.25 per share. | 19 Apr 2021 | 1,000 | 4,250 (0%) | 0% | 10.3 | 10,250 | Daxor Common Stock |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 146 | 4,184 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 275 | 4,038 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 1,191 | 30,103 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 2,223 | 28,912 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2020 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2020 | 770 | 26,689 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 676 | 25,919 (0%) | 0% | 0 | Common Stock | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 1,352 | 25,243 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp. | Robert J. Michel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 10,000 | 10,000 | - | - | STOCK OPTION (right to buy) | |
| Bio-Key International Inc. | Robert J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 527 | 23,891 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges